Skip to main content
. 2020 Jun 24;9(13):e014385. doi: 10.1161/JAHA.119.014385

Table 1.

Demographic Characteristics by Quintile of Growth Differentiation Factor‐15 (N=2873)

Overall (N=2873) Quintile 1 ≤856 pg/mL (N=579) Quintile 2 857 to 1200 pg/mL (N=570) Quintile 3 1201 to 1570 pg/mL (N=575) Quintile 4 1571 to 2220 pg/mL (N=574) Quintile 5 >2220 pg/mL (N=575)
Demographics
Age 59 (10.8) 53 (11.3) 58 (11.0) 60 (10.5) 62 (9.2) 62 (9.0)
Male 1558 (54) 287 (50) 304 (53) 315 (55) 313 (55) 339 (59)
Race/ethnicity
Non‐Hispanic white 1314 (46) 334 (58) 266 (47) 277 (48) 237 (41) 200 (35)
Non‐Hispanic black 1111 (39) 192 (33) 222 (39) 209 (36) 242 (42) 246 (43)
Hispanic 324 (11) 30 (5) 48 (8) 72 (13) 69 (12) 105 (18)
Other 124 (4) 23 (4) 34 (6) 17 (3) 26 (5) 24 (4)
Comorbidities
Cardiovascular disease 806 (28) 68 (12) 120 (21) 175 (30) 218 (38) 225 (39)
Myocardial infarction/prior revascularization 530 (18) 47 (8) 82 (14) 108 (19) 143 (25) 150 (26)
Chronic obstructive pulmonary disease 121 (4) 14 (2) 22 (4) 30 (5) 23 (4) 32 (6)
Atrial fibrillation 419 (15) 70 (12) 65 (11) 84 (15) 94 (16) 106 (18)
Stroke 269 (9) 19 (3) 39 (7) 59 (10) 78 (14) 74 (13)
Diabetes mellitus 1341 (47) 100 (17) 207 (36) 295 (51) 338 (59) 401 (70)
Clinical variables
Systolic blood pressure, mm Hg 126.4 (21.3) 118.5 (18.2) 123.5 (19.5) 125.8 (19.8) 130.8 (21.9) 133.8 (23.4)
Body mass index, kg/m2 32 (7.6) 31 (7.2) 32 (7.5) 33 (7.6) 32 (7.7) 32 (7.8)
Current smoking 340 (12) 26 (4) 45 (8) 67 (12) 94 (16) 108 (19)
Laboratory variables
Estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration), mL/min per 1.73 m2 43.2 (15.7) 58.1 (13.3) 46.4 (12.2) 41.1 (12.5) 37.3 (13.2) 32.6 (13.8)
Urinary protein to creatinine ratio from 24 h urine test 117 (52–602) 60 (39–107) 92 (48–332) 123 (54–530) 178 (62–905) 448 (121–1958)
Ejection fraction, % 55.3 (7.3) 55.2 (7.1) 55.8 (7.1) 55.4 (7.1) 55.3 (7.4) 54.5 (7.7)
Left ventricular mass index, g 62.8 (22.3) 54.6 (20.1) 59.7 (19.8) 63.2 (20.7) 66.5 (22.2) 71.9 (24.9)
Medications
Angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker 1972 (69) 314 (54) 411 (72) 427 (74) 423 (74) 397 (69)
Diuretics 1616 (56) 204 (35) 290 (51) 353 (61) 373 (65) 396 (69)
Beta blockers 1349 (47) 173 (30) 259 (45) 276 (48) 315 (55) 326 (57)

Entries are mean (SD) for continuous covariates or N (%) for categorical covariates, except as noted.